Archives
Deadlines loom for registering many classes of medical devices in India
India’s moves to strengthen regulations on the sale of medical devices are creating significant task lists for manufacturers, as registration deadlines approach for obtaining import and manufacturing licenses for devices that did not previously require such approvals. Beginning in November and extending... Read More
Demand for in vitro diagnostic testing growing rapidly in Asia-Pacific
Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia. ... Read More
Clinical trial participation plunges worldwide, in Asia due to COVID-19 pandemic
The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold. In Korea, the number of new patients enrolling in clinical... Read More
In Many Asian Markets, Pandemic Making Telemedicine the New Normal
This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More
RAPS Wisconsin Chapter Webcast: Embracing The Growth – An Update on MedTech in Asia
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More
Cloud Computing Technology Proving Indispensable Amid Pandemic in Asia
This article was originally published on MedTech Intelligence. Led by Chinese Internet commerce giants Tencent and Alibaba, internet providers have been offering a vast array of cloud computing services free to researchers and clinicians, while hiking their investment in advanced technologies, since... Read More
India Restricts Exports of Some Pharmaceutical Ingredients and Formulations including chloroquine phosphate, an API which Trump says is used for treatment of COVID-19
Concerned India may lack sufficient supply of drugs to treat symptoms of the COVID-19 virus, the Indian government will restrict exports of certain pharmaceuticals produced within its borders, India’s Ministry of Commerce and Industry announced on March 3. Among the 26 active... Read More
Artificial Intelligence Boom in Asia increasingly affecting collection of data, disease research
As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
India’s Regulatory Agency Clarifies Definition of Implantable Medical Device
Responding to concerns from medical device manufacturers, India’s national regulatory body for pharmaceuticals and medical devices has issued a clarification of what is considered an implantable medical device. Under a new definition published in December by the Central Drugs Standard Control Organization... Read More